Clene Inc Stock Today
| CLNN Stock | USD 0.33 0.03 8.33% |
Performance0 of 100
| Odds Of DistressOver 85
|
Clene is selling at 0.33 as of the 16th of April 2024; that is -8.33 percent decrease since the beginning of the trading day. The stock's open price was 0.36. Clene has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Clene Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of April 2022 and ending today, the 16th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 31st of December 2020 | Category Healthcare | Classification Health Care |
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company has 128.43 M outstanding shares of which 162.89 K shares are currently shorted by private and institutional investors with about 0.25 trading days to cover. More on Clene Inc
Moving together with Clene Stock
| 0.7 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
Moving against Clene Stock
| 0.69 | RZLT | Rezolute Trending | PairCorr |
| 0.65 | INDP | Indaptus Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.6 | ERAS | Erasca Inc Financial Report 20th of May 2024 | PairCorr |
| 0.6 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
| 0.58 | CELC | Celcuity LLC Financial Report 20th of May 2024 | PairCorr |
| 0.45 | MRK | Merck Company Report 25th of April 2024 | PairCorr |
| 0.44 | CCCC | C4 TherapeuticsInc Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 10th of May 2024
Clene Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Clene's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Clene or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO | Robert MBA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Clene report their recommendations after researching Clene's financial statements, talking to executives and customers, or listening in on Clene's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Clene Inc. The Clene consensus assessment is calculated by taking the average forecast from all of the analysts covering Clene. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Clene's historical financial statements, Clene Inc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Clene Inc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clene's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Clene's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Clene's financial leverage. It provides some insight into what part of Clene's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clene Inc (CLNN) is traded on NASDAQ Exchange in USA. It is located in 6550 South Millrock Drive, Salt Lake City, UT, United States, 84121 and employs 82 people. Clene is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 45.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clene's market, we take the total number of its shares issued and multiply it by Clene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Clene Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 128.43 M outstanding shares of which 162.89 K shares are currently shorted by private and institutional investors with about 0.25 trading days to cover.
Clene Inc currently holds about 16.23 M in cash with (30.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22.
Check Clene Probability Of Bankruptcy
Ownership AllocationClene holds a total of 128.43 Million outstanding shares. Clene Inc retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Clene Ownership Details
Clene Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Clene jumping above the current price in 90 days from now is close to 99%. The Clene Inc probability density function shows the probability of Clene stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.1044 suggesting Clene Inc market returns are highly reactive to returns on the market. As the market goes up or down, Clene is expected to follow. Additionally, clene Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Clene to move above the current price in 90 days from now is close to 99 (This Clene Inc probability density function shows the probability of Clene Stock to fall within a particular range of prices over 90 days) .
Clene Historical Income Statement
Clene Inc Income Statement is one of the three primary financial statements used for reporting Clene's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Clene Inc revenue and expense. Clene Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Clene's Interest Expense is very stable compared to the past year. As of the 16th of April 2024, Depreciation And Amortization is likely to grow to about 1.8 M, while EBIT is likely to drop (42.6 M). View More FundamentalsClene Stock Against Markets
Picking the right benchmark for Clene stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Clene stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Clene is critical whether you are bullish or bearish towards Clene Inc at a given time. Please also check how Clene's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Clene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Clene Corporate Management
Elected by the shareholders, the Clene's board of directors comprises two types of representatives: Clene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clene. The board's role is to monitor Clene's management team and ensure that shareholders' interests are well served. Clene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert MD | Chief Officer | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Tae Mgt | Consultant | Profile | |
| Mark ESQ | Chief Officer | Profile | |
| Michael Hotchkin | Chief Officer | Profile | |
| Mark Mortenson | CoFounder Officer | Profile |
How to buy Clene Stock?
Before investing in Clene, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Clene. To buy Clene stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Clene. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Clene stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Clene Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Clene Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Clene Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Clene Stock please use our How to Invest in Clene guide.
Already Invested in Clene Inc?
The danger of trading Clene Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Clene is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Clene. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Clene Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clene Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Clene Stock analysis
When running Clene's price analysis, check to measure Clene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clene is operating at the current time. Most of Clene's value examination focuses on studying past and present price action to predict the probability of Clene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clene's price. Additionally, you may evaluate how the addition of Clene to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Clene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.614 | Earnings Share (0.47) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0.27) | Return On Assets (0.52) |
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.